EIF4BP9

Across TCGA pan-cancer cohorts, EIF4BP9 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of EIF4BP9’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where EIF4BP9 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EIF4BP9 is over-expressed in tumor, although a few such as BRCA and THCA show the opposite, repressed pattern.

COAD, PRAD, and BRCA are the cancer types where EIF4BP9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EIF4BP9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	+0.173	.007	5	view →
PRAD	All	All	+0.036	.005	2	view →
BRCA	Female	All	−0.025	.002	2	view →
THCA	Male	All	−0.034	.026	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

EIF4BP9–COAD

Open the COAD breakdown →